Clinical trial for Sjögren's Syndrome
Official title Evaluation of the Prevalence, and Immunological Characteristics of Small Fiber Neuropathy in Patients With Primary Sjögren's Syndrome
ClinicalTrials.gov ID: NCT07917442
What this study is testing
- What it's testing
- The investigators propose to conduct a study evaluating the prevalence of SNN in pSS patients and to find clinical characteristics and specific immunological profiles in pSS patients with SFN.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 and older
You may be able to join if
- Age ≥ 18 years
- Primary Sjögren's syndrome confirmed according to ACR/EULAR criteria 2016
- Body Mass Index between 18 and 35 kg/m²
You likely can't join if
- Secondary or unconfirmed Sjögren's syndrome,
- Age \< 18 years, Use of medications that could interfere with Sudoscan results and which could not be discontinued before inclusion,
- Other conditions that may cause small fiber neuropathy,
- type 2 diabetes,
- excessive alcohol consumption,
- sarcoidosis
See the full eligibility criteria
- Age ≥ 18 years
- Primary Sjögren's syndrome confirmed according to ACR/EULAR criteria 2016
- Body Mass Index between 18 and 35 kg/m²
- Secondary or unconfirmed Sjögren's syndrome,
- Age \< 18 years, Use of medications that could interfere with Sudoscan results and which could not be discontinued before inclusion,
- Other conditions that may cause small fiber neuropathy,
- type 2 diabetes,
- excessive alcohol consumption,
- sarcoidosis
- obesity
The study team makes the final eligibility decision.
Where it is enrolling
- Amiens, France
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part, but confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years and older. The study team makes the final eligibility decision.
Where is this trial taking place?
This study is enrolling now at Amiens, France. Enter your location above to see the nearest enrolling site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool that is independent of the study sponsor. Details come from ClinicalTrials.gov. The study team decides eligibility, and your own doctor gives medical advice.